Work Here?
Journey Clinical
Work Here?
Ketamine-assisted psychotherapy with medical oversight
Journey Clinical
Work Here?
Ketamine-assisted psychotherapy with medical oversight
Overview
Journey Clinical offers Ketamine-Assisted Psychotherapy (KAP) for depression, anxiety, and PTSD. It acts as a one-stop treatment partner where a medical consultation leads to ketamine prescription, administration, and accompanying psychotherapy in a coordinated care plan. The approach blends ketamine's effects with structured psychotherapy to tackle symptoms from multiple angles under medical oversight. The company stands out with a patient-centered, collaborative care model and a team of MDs, PhDs, and licensed clinicians delivering personalized, accessible therapy.
About Journey Clinical
Industries
Healthcare
Company Size
51-200
Company Stage
Series A
Total Funding
$11.5M
Headquarters
New York City, null
Founded
2020
Get referred to Journey Clinical
See people who can refer or advise you
Simplify's Take
What believers are saying
- Journey Clinical now accepts many major insurers, reducing patient out-of-pocket costs.
- The company added 2026 resources and sessions around psychedelics after the White House order.
- Expanded state coverage and partner therapists create distribution for future psilocybin therapies.
What critics are saying
- Schedule I regulation still blocks psilocybin, MDMA, and broad payer reimbursement today.
- Competitors like Spravato and psychiatric telehealth platforms can absorb ketamine demand.
- If insurance reimbursement tightens, therapist acquisition slows and Journey Clinical's network economics break.
What makes Journey Clinical unique
- Journey Clinical runs the largest U.S. licensed therapist network for psychedelic-assisted psychotherapy.
- It combines in-house medical prescribing, therapist training, and insurance billing across 30 states.
- Its 2024 Compass Pathways collaboration positions it for psilocybin delivery infrastructure.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$11.5M
Below
Industry Average
Funded Over
2 Rounds
Industry standards
Benefits
Flexible Work Hours
Remote Work Options
Training Programs
Hybrid Work Options
Growth & Insights and Company News
6 month growth
↓ -1%1 year growth
↑ 3%2 year growth
↑ 5%For those curious to learn more, The Juniper Center has partnered with Journey Clinical - a platform that connects therapists with licensed prescribers and offers research and resources on KAP for both clients and providers.
Gateway to Solutions, a trusted provider of ketamine-assisted psychotherapy for eight years, has recently partnered with Journey Clinical for a seamless and collaborative KAP experience.
Compass Pathways plc (Nasdaq: CMPS) entered into a research collaboration agreement this week with Journey Clinical, a U.S.-based psychedelic-assisted psychotherapy platform.
This October, Journey Clinical launched a partnership with the Integrative Psychiatry Institute (IPI) to support their students and graduates in becoming successful Ketamine-Assisted Psychotherapy providers.
Journey Clinical partnered up with Fluence to offer some training and then they also needed professional resource in order to grow their practice.
Journey Clinical is Hiring for 16 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Journey Clinical
Industries
Healthcare
Company Size
51-200
Company Stage
Series A
Total Funding
$11.5M
Headquarters
New York City, null
Founded
2020
Journey Clinical is Hiring for 16 Jobs on Simplify!
Find jobs on Simplify and start your career today